查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786949

抗体探索市场，规模，占有率，趋势，产业分析报告:各方法，抗体类别，各终端用户，各地区-2025～2034年市场预测

Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，抗体发现市场规模将达到 204.1 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

抗体发现是识别和开发特异性结合病毒、细菌和癌细胞等标靶的抗体的过程。有效抗体的分离和优化通常使用杂交瘤技术、噬菌体展示和单一 B 细胞筛选等技术。之后，研究人员对这些抗体进行表征和测试，以确定其在诊断、治疗或研究中的潜在用途。

个人化医疗正在改变疾病的治疗方式，其重点是针对个别基因组成和病理进行量身定制的治疗方案。抗体在这一方法中发挥关键作用，因为它们可以被设计成靶向体内特定分子，例如癌细胞中的分子。随着越来越多的人和医生倾向于更精准、副作用更少的治疗，对客製化抗体疗法的需求也日益增长。这种转变在肿瘤学等领域尤其重要，因为没有哪两个患者对治疗的反应完全相同。抗体发现技术能够识别和开发针对不同患者群体的高度特异性治疗方法。这一趋势正鼓励製药公司加大对个人化治疗研究的投入。随着个人化医疗的认知度和成功案例的增多，抗体发现市场将持续发展，并成为未来医疗保健的关键。

生技公司、大型製药公司、学术机构和实验室之间的策略联盟在抗体发现的推进中发挥着重要作用。这种伙伴关係使不同的组织能够共享资源、知识和技术，使药物发现过程更快、更有效率。实验室可能拥有先进的技术设备，而製药公司可能拥有资金和生产能力。合作研究也有助于管理与药物开发相关的高成本和风险。目前，许多公司正在签订共同开发和授权协议，以共享利益和责任。这一趋势推动着越来越多的抗体药物进入临床试验并最终惠及患者。

抗体发现市场报告重点

到2024年，噬菌体展示技术将占最大的市场占有率，因为它具有多功能性、可靠性以及在相对较短的时间内生产高亲和力抗体的能力。

由于人们越来越关注开发包括单株抗体在内的生物製剂，以治疗包括癌症、自体免疫疾病和传染病在内的多种疾病，预计製药生物技术产业将在预测期内经历显着增长。

到2024年，由于强大的生物医学研究基础设施和对生命科学的持续投资，北美将占抗体发现市场的最大占有率。

由于生技产业的扩张、政府的支持以及对医疗保健研究的投入增加，亚太抗体发现市场正在经历显着成长。

全球主要市场参与者包括 Biocytogen、Charles River Laboratories、Creative Biolabs、Danaher Corporation、Eurofins Scientific、Evotec、Fairjourney Biologics S.A.、Genscript Technology Corporation、Sartorius AG 和 Twist Bioscience。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球抗体发现市场洞察

  • 市场概述
  • 抗体发现市场动态
    • 促进因素和机会
      • 慢性病和传染病的流行
      • 生物製药研发投入的增加
    • 限制因素与挑战
      • 初始製造成本高
  • PESTEL分析
  • 抗体发现市场趋势
  • 价值链分析

第5章 全球抗体发现市场:各方法

  • 主要调查结果
  • 简介
  • 噬菌体显示器
  • 融合瘤
  • 其他

第6章 全球抗体发现市场:抗体类别

  • 主要调查结果
  • 简介
  • 人体化抗体
  • 人抗体
  • 嵌合抗体
  • 鼠标抗体

第7章 全球抗体发现市场:各终端用户

  • 主要调查结果
  • 简介
  • 製药生物科技产业
  • 实验室
  • 学术实验室

第8章 全球抗体发现市场:地区

  • 主要调查结果
  • 简介
    • 抗体发现市场评估:地区，2020～2034年
  • 北美
    • 北美:各方法，2020～2034年
    • 北美:抗体类别，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各方法，2020～2034年
    • 欧洲:抗体类别，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他的欧洲
  • 亚太地区
    • 亚太地区:各方法，2020～2034年
    • 亚太地区:抗体类别，2020～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东·非洲
    • 中东·非洲:各方法，2020～2034年
    • 中东·非洲:抗体类别，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他的中东·非洲
  • 南美
    • 南美:各方法，2020～2034年
    • 南美:抗体类别，2020～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Biocytogen
  • Charles River Laboratories
  • Creative Biolabs
  • Danaher Corporation
  • Eurofins Scientific
  • Evotec
  • Fairjourney Biologics S.A
  • Genscript Technology Corporation
  • Sartorius AG
  • Twist Bioscience
Product Code: PM5947

The antibody discovery market size is expected to reach USD 20.41 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody discovery is the process of identifying and developing antibodies that can specifically bind to a target, such as a virus, bacterium, or cancer cell. It involves techniques such as hybridoma technology, phage display, or single B-cell screening to isolate and optimize effective antibodies. These antibodies are then characterized and tested for their potential use in diagnostics, therapeutics, or research.

Personalized medicine is transforming the way diseases are treated by focusing on therapies that are tailored to an individual's genetic makeup and condition. Antibodies play a key role in this approach as they can be engineered to target specific molecules in the body, such as those found in cancer cells. The demand for customized antibody therapies is rising as more people and doctors prefer treatments that are more precise and have fewer side effects. This shift is especially important in fields such as oncology, where no two patients respond exactly the same way to treatment. Antibody discovery technologies enable the identification and development of highly specific treatments tailored to different patient groups. This trend is encouraging pharmaceutical companies to invest more in research that supports personalized approaches. As awareness and success stories around personalized medicine grow, it pushes the antibody discovery market forward, making it an essential part of future healthcare.

Strategic collaborations between biotech companies, pharmaceutical giants, academic institutions, and research labs are playing a big role in advancing antibody discovery. These partnerships allow different organizations to share resources, knowledge, and technology, making the discovery process faster and more effective. A research lab may have an advanced technological setup, while a pharmaceutical company may have the funding and manufacturing capabilities. Collaborations further help in managing the high cost and risk associated with drug development. Many companies now enter co-development or licensing agreements to share profits and responsibilities. This trend has led to a growing number of antibody-related drugs entering clinical trials and eventually reaching patients.

Antibody Discovery Market Report Highlights

In 2024, the phage display segment dominated with the largest share due to its versatility, reliability, and ability to produce high-affinity antibodies in a relatively short time.

The pharmaceutical and biotechnology industry segment is expected to experience significant growth during the forecast period as these companies are increasingly focused on developing biologic drugs, including monoclonal antibodies, to treat a wide range of conditions such as cancer, autoimmune diseases, and infectious diseases.

In 2024, North America dominated the antibody discovery market with the largest share due to its strong biomedical research infrastructure and consistent investments in life sciences.

The Asia Pacific antibody discovery market is experiencing significant growth driven by expanding biotech industries, supportive government initiatives, and increasing investments in healthcare research.

A few global key market players are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, and Twist Bioscience.

Polaris Market Research has segmented the antibody discovery market report on the basis of method, antibody type, end user, and region:

By Method (Revenue - USD Billion, 2020-2034)

Phage Display

Hybridoma

Others

By Antibody Type (Revenue - USD Billion, 2020-2034)

Humanized Antibody

Human Antibody

Chimeric Antibody

Murine Antibody

By End User (Revenue - USD Billion, 2020-2034)

Pharmaceutical and Biotechnology industry

Research laboratory

Academic laboratory

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antibody Discovery Market Insights

  • 4.1. Antibody Discovery Market - Market Snapshot
  • 4.2. Antibody Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Prevalence of Chronic and Infectious Disease
      • 4.2.1.2. Increase in Investment in Biopharmaceutical R&D
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Cost of Manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibody Discovery Market Trends
  • 4.6. Value Chain Analysis

5. Global Antibody Discovery Market, by Method

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 5.3. Phage Display
    • 5.3.1. Global Antibody Discovery Market, by Phage Display, by Region, 2020-2034 (USD billion)
  • 5.4. Hybridoma
    • 5.4.1. Global Antibody Discovery Market, by Hybridoma, by Region, 2020-2034 (USD billion)
  • 5.5. Others
    • 5.5.1. Global Antibody Discovery Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Antibody Discovery Market, by Antibody Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 6.3. Humanized Antibody
    • 6.3.1. Global Antibody Discovery Market, by Humanized Antibody, by Region, 2020-2034 (USD billion)
  • 6.4. Human Antibody
    • 6.4.1. Global Antibody Discovery Market, by Human Antibody, by Region, 2020-2034 (USD billion)
  • 6.5. Chimeric Antibody
    • 6.5.1. Global Antibody Discovery Market, by Chimeric Antibody, by Region, 2020-2034 (USD billion)
  • 6.6. Murine Antibody
    • 6.6.1. Global Antibody Discovery Market, by Murine Antibody, by Region, 2020-2034 (USD billion)

7. Global Antibody Discovery Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 7.3. Pharmaceutical and Biotechnology industry
    • 7.3.1. Global Antibody Discovery Market, by Pharmaceutical and Biotechnology industry, by Region, 2020-2034 (USD billion)
  • 7.4. Research laboratory
    • 7.4.1. Global Antibody Discovery Market, by Research laboratory, by Region, 2020-2034 (USD billion)
  • 7.5. Academic laboratory
    • 7.5.1. Global Antibody Discovery Market, by Academic laboratory, by Region, 2020-2034 (USD billion)

8. Global Antibody Discovery Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
  • 8.3. Antibody Discovery Market - North America
    • 8.3.1. North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.3.2. North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.3.3. North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.3.4. Antibody Discovery Market - U.S.
      • 8.3.4.1. U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.3.4.2. U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.3.4.3. U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.3.5. Antibody Discovery Market - Canada
      • 8.3.5.1. Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.3.5.2. Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.3.5.3. Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4. Antibody Discovery Market - Europe
    • 8.4.1. Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.2. Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.3. Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.4. Antibody Discovery Market - UK
      • 8.4.4.1. UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.4.2. UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.4.3. UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.5. Antibody Discovery Market - France
      • 8.4.5.1. France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.5.2. France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.5.3. France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.6. Antibody Discovery Market - Germany
      • 8.4.6.1. Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.6.2. Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.6.3. Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.7. Antibody Discovery Market - Italy
      • 8.4.7.1. Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.7.2. Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.7.3. Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.8. Antibody Discovery Market - Spain
      • 8.4.8.1. Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.8.2. Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.8.3. Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.9. Antibody Discovery Market - Netherlands
      • 8.4.9.1. Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.9.2. Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.9.3. Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.10. Antibody Discovery Market - Russia
      • 8.4.10.1. Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.10.2. Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.10.3. Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.11. Antibody Discovery Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.11.2. Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.11.3. Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5. Antibody Discovery Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.2. Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.3. Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.4. Antibody Discovery Market - China
      • 8.5.4.1. China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.4.2. China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.4.3. China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.5. Antibody Discovery Market - India
      • 8.5.5.1. India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.5.2. India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.5.3. India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.6. Antibody Discovery Market - Malaysia
      • 8.5.6.1. Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.6.2. Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.6.3. Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.7. Antibody Discovery Market - Japan
      • 8.5.7.1. Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.7.2. Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.7.3. Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.8. Antibody Discovery Market - Indonesia
      • 8.5.8.1. Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.8.2. Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.8.3. Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.9. Antibody Discovery Market - South Korea
      • 8.5.9.1. South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.9.2. South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.9.3. South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.10. Antibody Discovery Market - Australia
      • 8.5.10.1. Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.10.2. Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.10.3. Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.11. Antibody Discovery Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6. Antibody Discovery Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.2. Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.3. Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.4. Antibody Discovery Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.4.2. Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.4.3. Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.5. Antibody Discovery Market - UAE
      • 8.6.5.1. UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.5.2. UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.5.3. UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.6. Antibody Discovery Market - Israel
      • 8.6.6.1. Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.6.2. Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.6.3. Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.7. Antibody Discovery Market - South Africa
      • 8.6.7.1. South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.7.2. South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.7.3. South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.8. Antibody Discovery Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7. Antibody Discovery Market - Latin America
    • 8.7.1. Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.2. Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.3. Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.4. Antibody Discovery Market - Mexico
      • 8.7.4.1. Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.4.2. Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.4.3. Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.5. Antibody Discovery Market - Brazil
      • 8.7.5.1. Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.5.2. Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.5.3. Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.6. Antibody Discovery Market - Argentina
      • 8.7.6.1. Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.6.2. Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.6.3. Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.7. Antibody Discovery Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.7.2. Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.7.3. Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biocytogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Method Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Charles River Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Method Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Creative Biolabs
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Method Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Method Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eurofins Scientific
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Method Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Evotec
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Method Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Fairjourney Biologics S.A
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Method Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Genscript Technology Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Method Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sartorius AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Method Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Twist Bioscience
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Method Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 2 Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 3 Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 4 North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 5 North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 6 North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 7 U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 8 U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 9 U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 10 Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 11 Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 12 Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 13 Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 14 Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 15 Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 16 UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 17 UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 18 UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 19 France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 20 France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 21 France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 22 Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 23 Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 24 Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 25 Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 26 Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 27 Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 28 Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 29 Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 30 Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 31 Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 32 Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 33 Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 34 Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 35 Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 36 Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 37 Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 38 Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 39 Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 40 Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 41 Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 42 Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 43 China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 44 China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 45 China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 46 India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 47 India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 48 India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 49 Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 50 Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 51 Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 52 Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 53 Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 54 Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 55 Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 56 Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 57 Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 58 South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 59 South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 60 South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 61 Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 62 Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 63 Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 64 Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 65 Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 66 Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 67 Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 68 Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 69 Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 70 Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 71 Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 72 Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 73 UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 74 UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 75 UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 76 Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 77 Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 78 Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 79 South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 80 South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 81 South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 82 Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 83 Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 84 Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 85 Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 86 Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 87 Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 88 Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 89 Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 90 Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 91 Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 92 Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 93 Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 94 Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 95 Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 96 Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 97 Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 98 Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 99 Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Antibody Discovery Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Method
  • Figure 7. Global Antibody Discovery Market, by Method, 2024 & 2034 (USD billion)
  • Figure 8. Market by Antibody Type
  • Figure 9. Global Antibody Discovery Market, by Antibody Type, 2024 & 2034 (USD billion)
  • Figure 10. Market by End User
  • Figure 11. Global Antibody Discovery Market, by End User, 2024 & 2034 (USD billion)
  • Figure 12. Global Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 13. Strategic Analysis - Global Antibody Discovery Market